Recent developments in CCR2 antagonists - PubMed (original) (raw)

Review

Recent developments in CCR2 antagonists

Mingde Xia et al. Expert Opin Ther Pat. 2009 Mar.

Abstract

Monocyte chemoattractant protein-1 (MCP-1) is a major chemoattractant for monocytes and memory T cells by means of their binding to its specific cell-surface receptor, CC-chemokine receptor-2 (CCR2). CCR2 belongs to the G-protein-coupled seven-transmembrane receptor superfamily. The evidence in favor of CCR2 and MCP-1 having dominant roles in monocyte chemotaxis and chronic inflammation was provided by CCR2 and MCP-1 knockout mice. It has been recognized that CCR2 antagonists are potential therapeutic agents in preventing, treating, or ameliorating a CCR2-mediated inflammatory syndrome or disease such as psoriasis, uveitis, rheumatoid arthritis, multiple sclerosis, asthma, obesity, and chronic obstructive pulmonary disease. This review summarizes recent developments in small-molecule CCR2 antagonists disclosed by patent applications published between 2005 and 2008 and related publications.

PubMed Disclaimer

Similar articles

• Cloning and functional characterization of the rabbit C-C chemokine receptor 2.
  Lu D, Yuan XJ, Evans RJ Jr, Pappas AT, Wang H, Su EW, Hamdouchi C, Venkataraman C. Lu D, et al. BMC Immunol. 2005 Jul 7;6:15. doi: 10.1186/1471-2172-6-15. BMC Immunol. 2005. PMID: 16001983 Free PMC article.
• Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies.
  Daly C, Rollins BJ. Daly C, et al. Microcirculation. 2003 Jun;10(3-4):247-57. doi: 10.1038/sj.mn.7800190. Microcirculation. 2003. PMID: 12851642 Review.
• HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo.
  Han KH, Ryu J, Hong KH, Ko J, Pak YK, Kim JB, Park SW, Kim JJ. Han KH, et al. Circulation. 2005 Mar 22;111(11):1439-47. doi: 10.1161/01.CIR.0000158484.18024.1F. Circulation. 2005. PMID: 15781755
• Pharmacological characterization of INCB3344, a small molecule antagonist of human CCR2.
  Shin N, Baribaud F, Wang K, Yang G, Wynn R, Covington MB, Feldman P, Gallagher KB, Leffet LM, Lo YY, Wang A, Xue CB, Newton RC, Scherle PA. Shin N, et al. Biochem Biophys Res Commun. 2009 Sep 18;387(2):251-5. doi: 10.1016/j.bbrc.2009.06.135. Epub 2009 Jul 1. Biochem Biophys Res Commun. 2009. PMID: 19576173
• Novel C-C chemokine receptor 2 antagonists in metabolic disease: a review of recent developments.
  Kang YS, Cha JJ, Hyun YY, Cha DR. Kang YS, et al. Expert Opin Investig Drugs. 2011 Jun;20(6):745-56. doi: 10.1517/13543784.2011.575359. Epub 2011 Apr 6. Expert Opin Investig Drugs. 2011. PMID: 21466412 Review.

Cited by

• Targeting the CCL2/CCR2 Axis in Cancer Immunotherapy: One Stone, Three Birds?
  Fei L, Ren X, Yu H, Zhan Y. Fei L, et al. Front Immunol. 2021 Nov 3;12:771210. doi: 10.3389/fimmu.2021.771210. eCollection 2021. Front Immunol. 2021. PMID: 34804061 Free PMC article. Review.
• Preconditioning of Adipose-Derived Mesenchymal Stem-Like Cells with Eugenol Potentiates Their Migration and Proliferation In Vitro and Therapeutic Abilities in Rat Hepatic Fibrosis.
  Fathy M, Okabe M, M Othman E, Saad Eldien HM, Yoshida T. Fathy M, et al. Molecules. 2020 Apr 26;25(9):2020. doi: 10.3390/molecules25092020. Molecules. 2020. PMID: 32357508 Free PMC article.
• IL-2-controlled expression of multiple T cell trafficking genes and Th2 cytokines in the regulatory T cell-deficient scurfy mice: implication to multiorgan inflammation and control of skin and lung inflammation.
  Sharma R, Sharma PR, Kim YC, Leitinger N, Lee JK, Fu SM, Ju ST. Sharma R, et al. J Immunol. 2011 Jan 15;186(2):1268-78. doi: 10.4049/jimmunol.1002677. Epub 2010 Dec 17. J Immunol. 2011. PMID: 21169543 Free PMC article.
• Targeting CCR2 Receptor To Treat Inflammation Diseases and Disorders.
  Abdel-Magid AF. Abdel-Magid AF. ACS Med Chem Lett. 2013 Mar 1;4(4):371-2. doi: 10.1021/ml400055e. eCollection 2013 Apr 11. ACS Med Chem Lett. 2013. PMID: 24900677 Free PMC article. No abstract available.
• Thermodynamic Insights and Conceptual Design of Skin-Sensitive Chitosan Coated Ceramide/PLGA Nanodrug for Regeneration of Stratum Corneum on Atopic Dermatitis.
  Jung SM, Yoon GH, Lee HC, Jung MH, Yu SI, Yeon SJ, Min SK, Kwon YS, Hwang JH, Shin HS. Jung SM, et al. Sci Rep. 2015 Dec 15;5:18089. doi: 10.1038/srep18089. Sci Rep. 2015. PMID: 26666701 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Taylor & Francis

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal